Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins

Kim, J.; Reber, H. A.; Dry, S. M.; Elashoff, D.; Chen, S. L.; Umetani, N.; Kitago, M.; Hines, O. J.; Kazanjian, K. K.; Hiramatsu, S.; Bilchik, A. J.; Yong, S.; Shoup, M.; Hoon, D. S. B.
November 2006
Gut;Nov2006, Vol. 55 Issue 11, p1598
Academic Journal
Background: Despite intent to cure surgery with negative resection margins, locoregional recurrence is common in pancreatic cancer. Aims: To determine whether detection of K-ras gene mutation in the histologically negative surgical margins of pancreatic cancer reflects unrecognised disease. Patients: Seventy patients who underwent curative resection for pancreatic ductal adenocarcinoma were evaluated. Methods: All patients had surgical resection margins (pancreatic transection and retroperitoneal) that were histologically free of invasive cancer. DNA was extracted from these paraffin embedded surgical margins and assessed by quantitative real time polymerase chain reaction to detect the K-ras gene mutation at codon 12. Detection of K-ras mutation was correlated with standard clinicopathological factors. Results: K-ras mutation was detected in histologically negative surgical margins of 37 of 70 (53%) patients. A significant difference in overall survival was demonstrated between patients with margins that were K-ras mutation positive compared with negative (median 15 v 55 months, respectively; p = 0.0008). By univariate and multivariate analyses, detection of K-ras mutation in the margins was a significant prognostic factor for poor survival (hazard ratio (HR) 2.8 (95% confidence interval (CI) 1.5–5.3), p=0.0009; and HR 2.8 (95% CI 1.4–5.5), p=0.004, respectively). Conclusions: Detection of cells harbouring K-ras mutation in histologically negative surgical margins of pancreatic cancer may represent unrecognised disease and correlates with poor disease outcome. The study demonstrates that molecular-genetic evaluation of surgical resection margins can improve pathological staging and prognostic evaluation of patients with pancreatic ductal adenocarcinoma.


Related Articles

  • NBL1 and anillin (ANLN) genes over-expression in pancreatic carcinoma. Olakowski, Marek; Tyszkiewicz, Tomasz; Jarząb, Michał; Król, Robert; Oczko-Wojciechowska, Małgorzata; Kowalska, Małgorzata; Kowal, Monika; Gala, Grzegorz M.; Kajor, Maciej; Lange, Dariusz; Chmielik, Ewa; Gubala, Elzbieta; Lampe, Paweł; Jarząb, Barbara // Folia Histochemica et Cytobiologica;2009, Vol. 47 Issue 2, p249 

    The aim of the study was to analyze the gene expression profile of pancreatic cancer to derive novel molecular markers of this malignancy. The snap-frozen or RNA-later preserved samples of 18 pancreatic adenocarcinomas, 5 chronic pancreatitis cases and 6 specimens of grossly normal pancreas were...

  • Detection and Clinical Significance of CD44v6 and Integrin-β1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay. Zhou, Gang; Chiu, David; Qin, Dajiang; Niu, Lizhi; Cai, Jinlei; He, Lihua; Huang, Wenhao; Xu, Kecheng // Applied Biochemistry & Biotechnology;Aug2012, Vol. 167 Issue 8, p2257 

    The cell adhesion molecules CD44v6 and integrin-β1 are associated with the progression and metastasis of cancer. A novel triplex real-time reverse transcription polymerase chain reaction (qRT-PCR) assay was developed to quantify CD44v6 and integrin-β1 gene expression in peripheral blood...

  • Prognostic significance of microRNA-141 expression and its tumor suppressor function in human pancreatic ductal adenocarcinoma. Zhu, Zi-Man; Xu, Yue-Fang; Su, Qin-Jun; Du, Jun-Dong; Tan, Xiang-Long; Tu, Yu-Liang; Tan, Jing-Wang; Jiao, Hua-Bao // Molecular & Cellular Biochemistry;Mar2014, Vol. 388 Issue 1/2, p39 

    Increasing evidence shows that dysregulation of microRNAs is correlated with tumor development. This study was performed to determine the expression of miR-141 and investigate its clinical significance in pancreatic ductal adenocarcinoma (PDAC). Taqman quantitative RT-PCR was used to detect...

  • Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population. Tochigi, Naobumi; Dacic, Sanja; Nikiforova, Marina; Cieply, Kathleen M.; Yousem, Samuel A. // American Journal of Clinical Pathology;May2011, Vol. 135 Issue 5, p783 

    Molecular testing of pulmonary adenocarcinomas for EGFR and KRAS mutations is becoming more common as tyrosine kinase inhibitor therapy is used for EGFR-mutated adenocarcinomas. Adenosquamous carcinomas represent a hybrid carcinoma, and there is no literature addressing the frequency of EGFR and...

  • Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. Havlik, Roman; Srovnalb, Josef; Klos, Dusan; Benedikova, Andrea; Lovecek, Martin; Ghothim, Mohamed; Cahova, Dana; Neoral, Cestmir; Hajduch, Marian // Biomedical Papers of the Medical Faculty of Palacky University i;Sep2013, Vol. 157 Issue 3, p233 

    Aims. The aim of this study was to test the hypothesis that occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic adenocarcinoma. Methods. Real-time RT-PCR analysis of CEA, EGFR and hTERT transcript levels was used to identify occult tumour cells in peritoneal...

  • Hypermethylation of E-Cadherin and Estrogen Receptor-α Gene Promoter and Its Association with Clinicopathological Features of Breast Cancer in Iranian Patients. Rasti, Mozhgan; Entezam, Mona; Monabati, Ahmad // Iranian Journal of Medical Sciences;Sep2009, Vol. 34 Issue 3, p186 

    Background: Aberrant methylation of cytosine-guanine dinucleotide islands leads to inactivation of tumor suppressor genes in breast cancer. Tumor suppressor genes are unmethylated in normal tissue and often become hypermethylated during tumor formation, leading to gene silencing. We investigated...

  • Investigating the Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients with Breast Cancer. Tajadini, Mohammad Hassan; Khadem, Houra; Pourhosein, Meraj; Sabzghabaee, Ali Mohammad; Hemati, Simin; Sadeghi, Hamid Mirmohammad // Journal of Isfahan Medical School;Feb2013, Vol. 30 Issue 218, p2217 

    Background: Breast cancer is the most common cancer among women. Genetic is a proven risk factor in this disease. As breast cancer genes (BRCA1 and BRCA2) affect the incidence of this type of cancer, identification of mutation carriers is important in reduction of the overall risk. The purpose...

  • Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR. Dyrskjøt, L.; Reinert, T.; Novoradovsky, A.; Zuiverloon, T. C. M.; Beukers, W.; Zwarthoff, E.; Malats, N.; Real, F. X.; Segersten, U.; Malmström, P.-U.; Knowles, M.; Hurst, C.; Sorge, J.; Borre, M.; Ørntoft, T. F. // British Journal of Cancer;10/9/2012, Vol. 107 Issue 8, p1392 

    Background:Multiple clinical risk factors and genetic profiles have been demonstrated to predict progression of non-muscle invasive bladder cancer; however, no easily clinical applicable gene signature has been developed to predict disease progression independent of disease stage and...

  • Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma. Wright, C. M.; Dent, O. F.; Newlond, R. C.; Barker, M.; Chapuis, P. H.; Bokey, E. L.; Young, J. P.; Leggelt, B. A.; Jass, J. R.; Macdonald, G. A. // Gut;Jan2005, Vol. 54 Issue 1, p103 

    Background: Colorectal cancers (CRCs) may be categorised according to the degree of microsatellite instability (MSI) exhibited, as MSI-high (MSI-H), MSI-low (M5I-L), or microsatellite stable (MSS). MSI-H status confers a survival advantage to patients with sporadic CRC. Aims: To determine if low...


Read the Article


Sign out of this library

Other Topics